China Pharma Holdings, Inc.
CPHI
AMEX·Healthcare·Drug Manufacturers - Specialty & Generic·Mkt cap $33.2M
$0.82
▼ -2.38%
P/E
-3.04
Mkt Cap
$33.2M
52-Wk Range
$0.38–$19.19
52-Week Range
$0.38 - $19.19
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 53.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Average volatility.
Growth
No forward estimates available
Value
Valuation data unavailable
Momentum
Strong
+14.5% over 3m
Quality
Loss-making
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying CPHI right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
AUG 14, 2026
Most recent quarter reported revenue of $983.5K. Reported EPS of -$0.27.
Reported EPS · last 4Q
0 of 1 beats
Q3 26
—
Revenue trend · last 1Q
—
Q1 26
$983.5K
Margins · last 1Q
Profit
-116.2%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How CPHI stacks vs Drug Manufacturers - Specialty & Generic
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.